Mirtazapine
Product Images NDC 16590-155

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 16590-155). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mirtazapine 15mg Label Image (Mirtazapine 15mg 16590 153 Label)

This is a label of a medication containing Mirlazapine USP 15mg. It is packaged and distributed by JSA Gainesville, and the distributor is Walson Pharma, Inc. It may cause drowsiness, and each tablet should be taken with plenty of water. The NDC number is 1659015330. The lot number is not readable.*

FDA Label Image

Mirtazapine 30mg Label Image (Mirtazapine 30mg 16590 154 Label)

This is a description of a packaged medication containing Mirtazapine USP 30mg tablets. The medication is distributed by Walsun Pharme, Inc. and has a NDC number of 1659015460. The label warns that the medication may cause drowsiness or dizziness and that it should be taken as prescribed. The lot number and expiration date of the medication are provided.*

FDA Label Image

Mirtazapine 45mg Label Image (Mirtazapine 45mg 16590 155 Label)

Packaged and distributed by D STAT in Gainesville, the medication NDC 16590 155-30 contains one tablet of Mirtazapine USP 45mg. It is recommended to take the medication with plenty of water and may cause drowsiness. Furthermore, the medication should not be taken on behalf of someone else. NDC 0591- 1119-30 was approved and used as a sample on 11/15/2011.*

FDA Label Image

Mirtazapine Structural Formula (Mirtazapine Tablets 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.